Detalles de la búsqueda
1.
Two cases of bilateral reverse shoulder arthroplasty performed in patients with rheumatoid arthritis / Journal of Rural Medicine
Journal of Rural Medicine
; : 194-199, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-986395
2.
Efficacy of peficitinib in two patients with rheumatoid arthritis on maintenance hemodialysis / Journal of Rural Medicine
Journal of Rural Medicine
; : 193-195, 2022.
Artículo
en Inglés
| WPRIM | ID: wpr-936724
3.
SARS-CoV-2 Omicron BA.2 Variant Evades Neutralization by Therapeutic Monoclonal Antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-480166
4.
A soluble ACE2 microbody protein fused to a single immunoglobulin Fc domain is a potent inhibitor of SARS-CoV-2 infection in cell culture
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-300319
5.
SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-450959
6.
The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-444076
7.
MARCH8 targets cytoplasmic lysine residues of various viral envelope glycoproteins
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-440588
8.
B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-436620
9.
Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-431897
10.
The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-365270
11.
Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-463727
12.
Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-452771
13.
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-430003
14.
Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic Antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474369
15.
Intestinal organoids expose heterogeneity in SARS-CoV-2 susceptibility
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-452680
16.
High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-252353
17.
Delta-Omicron recombinant SARS-CoV-2 in a transplant patient treated with Sotrovimab
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-487325
18.
Neutralising antibodies against the SARS-CoV-2 Delta variant induced by Alhydroxyquim-II-adjuvanted trimeric spike antigens
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-456891
19.
SARS-CoV-2 Infects Syncytiotrophoblast and Activates Inflammatory Responses in the Placenta
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-446676
Resultados
1 -
19
de 19
1
Próxima >
>>